Histologic analyses of primary tumor tissues consistently showed that TPI-1 treatment alone increased CD8 infiltration, which was further increased when anti-PD-1 was combined with SHP-1 inhibition (Fig. 6d) with no observed effect on collagen deposition in either treatment group (Supplementary Fig. 10f). The gene discussed is NR0B2; the disease is neoplasm.